114 related articles for article (PubMed ID: 27774607)
1. Erythrocytosis in hepatocellular carcinoma portends poor prognosis by respiratory dysfunction secondary to mitochondrial DNA mutations.
Ke S; Chen S; Dong Z; Hong CS; Zhang Q; Tang L; Yang P; Zhai J; Yan H; Shen F; Zhuang Z; Wen W; Wang H
Hepatology; 2017 Jan; 65(1):134-151. PubMed ID: 27774607
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic Syndromes in Hepatocellular Carcinoma, Epidemiology, and Survival: A Retrospective Seven Years Study.
Burciu C; Sirli R; Bende R; Vuletici D; Miutescu B; Moga T; Bende F; Popescu A; Sporea I; Koppandi O; Miutescu E; Iovanescu D; Danila M
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674198
[No Abstract] [Full Text] [Related]
3. Farnesoid X receptor ablation sensitizes mice to hepatitis b virus X protein-induced hepatocarcinogenesis.
Niu Y; Xu M; Slagle BL; Huang H; Li S; Guo GL; Shi G; Qin W; Xie W
Hepatology; 2017 Mar; 65(3):893-906. PubMed ID: 28102638
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin production in hepatocellular carcinoma cells associated with polycythemia: immunohistochemical evidence.
Sakisaka S; Watanabe M; Tateishi H; Harada M; Shakado S; Mimura Y; Gondo K; Yoshitake M; Noguchi K; Hino T
Hepatology; 1993 Dec; 18(6):1357-62. PubMed ID: 7694895
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis.
Chen S; Dong Z; Yang P; Wang X; Jin G; Yu H; Chen L; Li L; Tang L; Bai S; Yan H; Shen F; Cong W; Wen W; Wang H
Cancer Lett; 2017 May; 394():22-32. PubMed ID: 28216372
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of combining high mobility group Box-1 and OV-6 expression in hepatocellular carcinoma.
Zhu J; Yu H; Chen S; Yang P; Dong Z; Ling Y; Tang H; Bai S; Yang W; Tang L; Shen F; Wang H; Wen W
Sci China Life Sci; 2018 Aug; 61(8):912-923. PubMed ID: 29441453
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.
Ren X; Wen W; Fan X; Hou W; Su B; Cai P; Li J; Liu Y; Tang F; Zhang F; Yang Y; He J; Ma W; He J; Wang P; Cao Q; Chen F; Chen Y; Cheng X; Deng G; Deng X; Ding W; Feng Y; Gan R; Guo C; Guo W; He S; Jiang C; Liang J; Li YM; Lin J; Ling Y; Liu H; Liu J; Liu N; Liu SQ; Luo M; Ma Q; Song Q; Sun W; Wang G; Wang F; Wang Y; Wen X; Wu Q; Xu G; Xie X; Xiong X; Xing X; Xu H; Yin C; Yu D; Yu K; Yuan J; Zhang B; Zhang P; Zhang T; Zhao J; Zhao P; Zhou J; Zhou W; Zhong S; Zhong X; Zhang S; Zhu L; Zhu P; Zou B; Zou J; Zuo Z; Bai F; Huang X; Zhou P; Jiang Q; Huang Z; Bei JX; Wei L; Bian XW; Liu X; Cheng T; Li X; Zhao P; Wang FS; Wang H; Su B; Zhang Z; Qu K; Wang X; Chen J; Jin R; Zhang Z
Cell; 2021 Apr; 184(7):1895-1913.e19. PubMed ID: 33657410
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapy for hepatocellular carcinoma: Challenges and opportunities.
Chen S; Cao Q; Wen W; Wang H
Cancer Lett; 2019 Sep; 460():1-9. PubMed ID: 31207320
[TBL] [Abstract][Full Text] [Related]
9. A human circulating immune cell landscape in aging and COVID-19.
Zheng Y; Liu X; Le W; Xie L; Li H; Wen W; Wang S; Ma S; Huang Z; Ye J; Shi W; Ye Y; Liu Z; Song M; Zhang W; Han JJ; Belmonte JCI; Xiao C; Qu J; Wang H; Liu GH; Su W
Protein Cell; 2020 Oct; 11(10):740-770. PubMed ID: 32780218
[TBL] [Abstract][Full Text] [Related]
10. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing.
Wen W; Su W; Tang H; Le W; Zhang X; Zheng Y; Liu X; Xie L; Li J; Ye J; Dong L; Cui X; Miao Y; Wang D; Dong J; Xiao C; Chen W; Wang H
Cell Discov; 2020; 6():31. PubMed ID: 32377375
[TBL] [Abstract][Full Text] [Related]
11. Soluble Fibers Improve Metabolic Syndrome but May Cause Liver Disease and Hepatocellular Carcinoma.
Wen W; Schwabe RF
Hepatology; 2019 Aug; 70(2):739-741. PubMed ID: 30762890
[No Abstract] [Full Text] [Related]
12. Chronic inflammation-elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance.
Li XF; Chen C; Xiang DM; Qu L; Sun W; Lu XY; Zhou TF; Chen SZ; Ning BF; Cheng Z; Xia MY; Shen WF; Yang W; Wen W; Lee TKW; Cong WM; Wang HY; Ding J
Hepatology; 2017 Dec; 66(6):1934-1951. PubMed ID: 28714104
[TBL] [Abstract][Full Text] [Related]
13. PTEN status determines chemosensitivity to proteasome inhibition in cholangiocarcinoma.
Jiang TY; Pan YF; Wan ZH; Lin YK; Zhu B; Yuan ZG; Ma YH; Shi YY; Zeng TM; Dong LW; Tan YX; Wang HY
Sci Transl Med; 2020 Sep; 12(562):. PubMed ID: 32967970
[TBL] [Abstract][Full Text] [Related]
14. Compartmentalized evolution of hepatitis B virus contributes differently to the prognosis of hepatocellular carcinoma.
Yin J; Chen X; Li N; Han X; Liu W; Pu R; Wu T; Ding Y; Zhang H; Zhao J; Han X; Wang H; Cheng S; Cao G
Carcinogenesis; 2021 Apr; 42(3):461-470. PubMed ID: 33247709
[TBL] [Abstract][Full Text] [Related]
15. PTEN deficiency facilitates the therapeutic vulnerability to proteasome inhibitor bortezomib in gallbladder cancer.
Jiang TY; Feng XF; Fang Z; Cui XW; Lin YK; Pan YF; Yang C; Ding ZW; Zhang YJ; Tan YX; Wang HY; Dong LW
Cancer Lett; 2021 Mar; 501():187-199. PubMed ID: 33220333
[TBL] [Abstract][Full Text] [Related]
16. NAD
Lv H; Lv G; Chen C; Zong Q; Jiang G; Ye D; Cui X; He Y; Xiang W; Han Q; Tang L; Yang W; Wang H
Cell Metab; 2021 Jan; 33(1):110-127.e5. PubMed ID: 33171124
[TBL] [Abstract][Full Text] [Related]
17. Targeted sequencing reveals the mutational landscape responsible for sorafenib therapy in advanced hepatocellular carcinoma.
Tang J; Sui CJ; Wang DF; Lu XY; Luo GJ; Zhao Q; Lian QY; Jeong S; Lin XM; Zhu YJ; Zheng B; Wu R; Wang Q; Liu XL; Liu JF; Xia Q; Wu G; Gu J; Wang HY; Chen L
Theranostics; 2020; 10(12):5384-5397. PubMed ID: 32373219
[No Abstract] [Full Text] [Related]
18. Adjuvant
Li J; Xing J; Yang Y; Liu J; Wang W; Xia Y; Yan Z; Wang K; Wu D; Wu L; Wan X; Yang T; Gao C; Si A; Wang H; Wu M; Lau WY; Chen Z; Shen F
Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):548-560. PubMed ID: 32164877
[TBL] [Abstract][Full Text] [Related]
19. High Serum Levels of Cholesterol Increase Antitumor Functions of Nature Killer Cells and Reduce Growth of Liver Tumors in Mice.
Qin WH; Yang ZS; Li M; Chen Y; Zhao XF; Qin YY; Song JQ; Wang BB; Yuan B; Cui XL; Shen F; He J; Bi YF; Ning G; Fu J; Wang HY
Gastroenterology; 2020 May; 158(6):1713-1727. PubMed ID: 31972238
[TBL] [Abstract][Full Text] [Related]
20. RPB5-Mediating Protein Promotes Cholangiocarcinoma Tumorigenesis and Drug Resistance by Competing With NRF2 for KEAP1 Binding.
Wan ZH; Jiang TY; Shi YY; Pan YF; Lin YK; Ma YH; Yang C; Feng XF; Huang LF; Kong XN; Ding ZW; Tan YX; Dong LW; Wang HY
Hepatology; 2020 Jun; 71(6):2005-2022. PubMed ID: 31541481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
